Search hospitals > Pennsylvania > Philadelphia
Abramson Cancer Center of the University of Pennsylvania
Claim this profilePhiladelphia, Pennsylvania 19104
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
947 reported clinical trials
74 medical researchers
Summary
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Cancer, Lung Cancer, Lymphoma and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 639 conditions. There are 74 research doctors associated with this hospital, such as Angela DeMichele, MD, Arati Desai, MD, Amy Clark, and Mark O'Hara, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
Stage III
2Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Angela DeMichele, MDAbramson Cancer Center of the University of Pennsylvania8 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
11 reported clinical trials
20 drugs studied
Arati Desai, MDAbrams Cancer Center of the University of Pennsylvania6 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
11 reported clinical trials
25 drugs studied
Amy ClarkUniversity of Pennsylvania1 year of reported clinical research
Studies Breast Cancer
Studies Breast cancer
10 reported clinical trials
29 drugs studied
Mark O'Hara, MDUniversity Of Pennsylvania2 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
9 reported clinical trials
20 drugs studied
Clinical Trials running at Abramson Cancer Center of the University of Pennsylvania
Breast Cancer
Esophageal Adenocarcinoma
Esophageal Carcinoma
Cancer
Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Lymphoma
Parotid Gland Cancer
Breast cancer
Bladder Cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Abramson Cancer Center of the University of Pennsylvania?
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Cancer, Lung Cancer, Lymphoma and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 639 conditions. There are 74 research doctors associated with this hospital, such as Angela DeMichele, MD, Arati Desai, MD, Amy Clark, and Mark O'Hara, MD.
Where is Abramson Cancer Center of the University of Pennsylvania located?
**Directions to Abramson Cancer Center, University of Pennsylvania, Philadelphia:**
- Take I-76 East to Exit 346B, University Avenue.
- Turn right onto Civic Center Boulevard.
- For real-time driving directions based on current traffic, consider using Waze.
Who should I call to ask about financial aid or insurance network?
**Abramson Cancer Center of the University of Pennsylvania - Financial and Insurance Assistance**
- **Financial Counseling Assistance:** Contact Tonya Boyer via email at Tonya.Boyer@pennmedicine.upenn.edu or by phone at 610-738-2510.
- **Insurance-Related Inquiries:** Reach out to Penn Medicine's customer service at 800-406-1177.
- **General Questions about Navigating Cancer Care:** Call 800-789-7366 (PENN).
What insurance does Abramson Cancer Center of the University of Pennsylvania accept?
The Abramson Cancer Center of the University of Pennsylvania accepts most major insurance plans. Patients are advised to confirm their insurance coverage with their provider before receiving care. Penn Medicine, including the Abramson Cancer Center, offers comprehensive care under various health plans, covering cancer and heart conditions.
What awards or recognition has Abramson Cancer Center of the University of Pennsylvania received?
The Abramson Cancer Center at the University of Pennsylvania is renowned for its exceptional cancer care, earning accolades from the Commission on Cancer (CoC). In 2023, four of its researchers were distinguished with prestigious awards from the American Association for Cancer Research (AACR).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.